Epilepsy is common, and many people keep having seizures despite medication. That is one reason researchers test natural compounds, and fisetin has been tried in several animal seizure models with mostly positive results: higher seizure thresholds, slower development of epilepsy, and less brain inflammation [1][2].
This is early-stage work. The studies use mice, rats and zebrafish, and one of the most positive results came from a nanoparticle form of fisetin rather than the plain compound. One cell study points the other way. There is no human trial of fisetin in epilepsy, and nothing on this page is a reason to change an antiseizure medicine.
Key Takeaways
- In mice, oral fisetin at 5 to 20 mg/kg raised the seizure threshold and dose-dependently slowed the development of PTZ kindling [1].
- In a pilocarpine model of temporal lobe epilepsy, fisetin loaded into nanoparticles protected against seizures at doses described as subtherapeutic for free fisetin [2].
- In cultured neurons, fisetin made zinc-induced damage worse, a reminder that its effects are not uniformly protective [3].
- No human trial has tested fisetin for epilepsy or seizures.
Important: This article describes animal and laboratory research and is not medical advice. Never stop, reduce or change the timing of an antiseizure medicine without your neurologist: doing so can trigger severe seizures. Fisetin can affect enzymes that clear many drugs, and several antiseizure medicines have a narrow safe range, so speak to your neurologist or pharmacist before adding it.
How seizure models work
Researchers cannot wait for animals to develop epilepsy on their own, so they trigger seizures in controlled ways. Pentylenetetrazole (PTZ) is a drug that blocks the brain’s main calming signal, GABA. A single large dose causes a seizure; small repeated doses cause kindling, where the brain becomes steadily more seizure-prone, which models how epilepsy develops. Electroshock tests measure how much current it takes to cause a seizure. Pilocarpine causes prolonged seizures followed by lasting temporal lobe epilepsy, the most common form in adults.
These models are how most antiseizure drugs were first found, so they are a reasonable starting point. But many compounds that work in them never reach patients, and none of them reproduces drug-resistant epilepsy in people well.
The kindling study
The most complete study gave mice oral fisetin at 5, 10 or 20 mg/kg [1]. In the electroshock test, fisetin raised the current needed to trigger a seizure. In acute PTZ tests, it lengthened the time before myoclonic jerks and generalised seizures began. In the kindling model, it dose-dependently suppressed the development of kindling and the nerve cell damage that came with it.
In the hippocampus and cortex, fisetin lowered a chain of inflammatory signals: HMGB1, TLR-4, IL-1R1, IL-1beta, IL-6 and TNF-alpha, along with NF-kappaB and COX-2 [1]. It also reduced the apoptosis markers cytochrome C and caspase-3 and lowered Akt/mTOR activation. The authors read this as a neuroprotective effect acting through inflammation and cell death.
Note the wording. Lengthening the time before a seizure and slowing kindling are real effects, but they are not the same as stopping seizures, and the abstract does not report how large the changes were.
Nanoparticles and temporal lobe epilepsy
Plain fisetin dissolves poorly and is broken down quickly, which limits how much reaches the brain. A 2024 study loaded it into chitosan nanoparticles and tested it in mice with pilocarpine-induced temporal lobe epilepsy [2]. The researchers used doses of both free fisetin and the nanoparticle form that they describe as subtherapeutic, and report that the nanoparticle form protected against seizures and against the depression-like behaviour and memory problems that followed. They link the effect to lower reactive oxygen species, TNF-alpha and the NLRP3 inflammasome in the brain.
A 2026 study went further, combining fisetin with carveol, a compound from plant oils, in lipid nanocapsules coated with mannose to help them cross the blood-brain barrier [4]. In a chronic PTZ model, given by injection, the coated version gave the best seizure control of the forms tested and improved anxiety- and depression-like behaviour. That is a two-compound formulation, so it cannot show what fisetin alone contributes.
Both studies make the same point in different ways: delivery is the bottleneck. A supplement capsule is not a brain-targeted nanoparticle. Our page on fisetin bioavailability covers what plain oral fisetin reaches in blood.
Traumatic epilepsy and zebrafish
Epilepsy can follow a serious head injury. In rats given 20 mg/kg of oral fisetin daily for 12 weeks before iron was injected into the brain to create post-traumatic epilepsy, fisetin prevented the development of electrical seizure activity on EEG, lowered lipid peroxides and eased the related memory problems [5]. Giving a compound for three months before an injury is not how anyone would use it in real life; our page on fisetin, TBI and concussion discusses that timing problem.
In adult zebrafish, fisetin isolated from the plant Bauhinia pentandra showed no toxicity, reduced anxiety-like behaviour and delayed seizures [6]. Computer docking suggested it may act on serotonin 5-HT3 receptors, which is a prediction rather than a measured effect. Fisetin and mood are covered on our page about fisetin, mood and anxiety.
The result that points the other way
Not every finding is protective. A 2006 study of zinc toxicity in cultured neurons, relevant because zinc released during seizures, stroke and trauma can kill nearby nerve cells, found that fisetin and resveratrol, both sirtuin activators, made the loss of the energy molecule NAD+ and the zinc damage worse [3]. Blocking the sirtuin pathway did the opposite and reduced the damage.
That is a culture study about NAD+ and sirtuins, not a seizure model, and it does not show that fisetin harms people with epilepsy. It does show that the same compound can help in one model and hurt in another, which is exactly why animal results need human testing before anyone relies on them.
What this means if you have epilepsy
A 2025 review places fisetin among many flavonoids with promising results in experimental epilepsy, and names target specificity and bioavailability as the main obstacles [7]. That is a fair summary. The signal is real in rodents, the mechanisms are plausible, and the human evidence is zero.
Antiseizure medicines are among the drugs where small changes in blood levels matter, which is why our page on fisetin drug interactions lists antiepileptics among the drugs to check before adding fisetin. If you want to try it, talk to your neurologist first, keep your medicines exactly as prescribed, and see fisetin side effects for what is known about safety.
Common questions
Does fisetin help epilepsy?
In mice it raised the seizure threshold and slowed the development of kindling [1]. It has not been tested in people with epilepsy.
Can fisetin replace antiseizure medication?
No. There are no human data, and stopping or changing an antiseizure medicine without medical supervision can cause severe seizures.
What dose of fisetin was used in seizure studies?
The mouse kindling study used 5, 10 and 20 mg/kg by mouth [1], and the traumatic epilepsy rat study used 20 mg/kg daily for 12 weeks [5]. Animal doses do not translate directly to human capsules.
Does fisetin reach the brain?
Poorly in its plain form, which is why recent studies used nanoparticles [2][4]. How much an oral supplement delivers to the human brain has not been measured.
Can fisetin harm nerve cells?
In one culture study it made zinc-induced damage to neurons worse [3]. Whether that matters in people is unknown.
References
- Neuroprotective Effect of Fisetin Through Suppression of IL-1R/TLR Axis and Apoptosis in Pentylenetetrazole-Induced Kindling in Mice. Front Neurol (2021). PMID 34354662
- Fisetin-loaded chitosan nanoparticles ameliorate pilocarpine-induced temporal lobe epilepsy and associated neurobehavioral alterations in mice: Role of ROS/TNF-alpha-NLRP3 inflammasomes pathway. Nanomedicine (2024). PMID 38740358
- Zinc neurotoxicity is dependent on intracellular NAD levels and the sirtuin pathway. Eur J Neurosci (2006). PMID 17042794
- Mannosylated fisetin/carveol lipid nanocapsules: brain-targeted dual therapy for modulation of epileptogenesis and cognitive deficits. Drug Deliv Transl Res (2026). PMID 40783676
- Antiepileptic effect of fisetin in iron-induced experimental model of traumatic epilepsy in rats in the light of electrophysiological, biochemical, and behavioral observations. Nutr Neurosci (2017). PMID 27198489
- Anxiolytic and Anticonvulsant Effects of Fisetin Isolated from Bauhinia pentandra on Adult Zebrafish (Danio rerio). Chem Biodivers (2024). PMID 39088251
- Recent Advances in Bioactive Flavonoids-based Nanotherapeutics as Promising Neuroprotectants in Epilepsy. Curr Aging Sci (2025). PMID 41704087
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.